Financial calendar 2024
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail| Nordecon AS' financial calendar for 2024: | ||
| Event | Due date | Due week |
| IV quarter and 12 months 2023 interim report | 08 February 2024 | 6 (2024) |
| Audited annual report 2023 | - | 16 (2024) |
| I quarter and 3 months 2024 interim report | 09 May 2024 | 19 (2024) |
| 2023 annual general meeting of shareholders | - | 21 (2024) |
| II quarter and half year 2024 interim report | 08 August 2024 | 32 (2024) |
| III quarter and 9 months 2024 interim report | 07 November 2024 | 45 (2024) |
| IV quarter and 12 months 2024 interim report | 06 February 2025 | 6 (2025) |
Nordecon (www.nordecon.com) is a group of construction companies whose core business is construction project management and general contracting in the buildings and infrastructures segment. Geographically the Group operates in Estonia, Finland, Ukraine and Sweden. The parent of the Group is Nordecon AS, a company registered and located in Tallinn, Estonia. The consolidated revenue of the Group in 2022 was 323 million euros. Currently Nordecon Group employs close to 570 people. Since 18 May 2006 the company's shares have been quoted in the main list of the Nasdaq Tallinn Stock Exchange.
Andri Hõbemägi
Nordecon AS
Head of Investor Relations
Tel: +372 6272 022
E-mail: [email protected]
www.nordecon.com
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 2026 Results of Annual General Meeting
- William Burns Launches SEO Agency in Bridgewater, MA: Burns SEO & Advertising
- World-First Achievement: SUSMED's Blockchain-Based Clinical Trial System Supports Successful Marketing Authorization for Pharmaceutical Product
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
